Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 5, 2023
Reporting Period: Event-based disclosure regarding upcoming investor conference presentations.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a regulatory disclosure regarding corporate events rather than a financial report.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces scheduled appearances by the Chief Executive Officer at industry conferences.
Guidance, Outlook, and Management Commentary
Upcoming Events:
- Morgan Stanley 21st Annual Global Healthcare Conference: Fireside chat on September 11, 2023, at 4:15 p.m. Eastern time.
- H.C. Wainwright 25th Annual Global Investment Conference: Corporate presentation on September 13, 2023, at 11:00 a.m. Eastern time.
- 2023 Cantor Global Healthcare Conference: Corporate presentation on September 27, 2023, at 1:50 p.m. Eastern time.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the conference presentations.
- Review the company's most recent 10-Q or 10-K filing for current financial metrics, as this 8-K contains no financial data.
- Monitor the scheduled conference dates for potential updates on clinical trials or strategic direction.